MONKEYPOX
Clinical trials for MONKEYPOX explained in plain language.
Never miss a new study
Get alerted when new MONKEYPOX trials appear
Sign up with your email to follow new studies for MONKEYPOX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mpox vaccine trial aims to protect High-Risk groups in colombia
⭐️ VACCINE ⭐️ OngoingThis study tests whether the LC16m8 vaccine can prevent mpox (monkeypox) in about 8,700 adults at high risk, including those with HIV. Participants are randomly assigned to get the vaccine right away or after a delay. Researchers will compare infection rates and side effects betw…
Matched conditions: MONKEYPOX
Phase: PHASE3 • Sponsor: Universidad Nacional de Colombia • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 00:25 UTC
-
Canadian trial tests monkeypox drug in outpatients
Disease control TerminatedThis study tests whether the drug tecovirimat helps non-hospitalized adults with monkeypox heal faster. About 120 participants will receive either the drug or a placebo. The goal is to see if the drug speeds up skin lesion recovery and if such a trial is practical in Canada.
Matched conditions: MONKEYPOX
Phase: PHASE3 • Sponsor: Marina Klein • Aim: Disease control
Last updated May 05, 2026 11:53 UTC
-
Mpox vaccine study aims to uncover immune secrets in HIV patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study will enroll 174 adults in New York City to see how well the mpox vaccine works in people with HIV compared to those without HIV. Researchers will test two ways of giving the vaccine: a low-dose shot in the forearm and a standard-dose shot in the upper arm. The goal is …
Matched conditions: MONKEYPOX
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:38 UTC